Shield Therapeutics plc (AIM:STX)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 3.300
+0.150 (4.76%)
Nov 10, 2026, 4:11 PM GMT
Shield Therapeutics Market Cap
Shield Therapeutics has a market cap or net worth of 35.31 million as of November 10, 2026. It is the 30,361st most valuable company in the world and the 678th biggest in the United Kingdom. Its market cap has decreased by 51.46% in one year.
Market Cap
35.31M
Enterprise Value
47.79M
Revenue
44.19M
Global Rank
Country Rank
#678 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 35.31M, a decrease of -79.20%. That is a compound annual growth rate of -13.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 35.31M | -66.24% |
| Dec 31, 2025 | 104.59M | 395.31% |
| Dec 31, 2024 | 21.12M | -59.70% |
| Dec 29, 2023 | 52.40M | 186.53% |
| Dec 30, 2022 | 18.29M | -80.96% |
| Dec 31, 2021 | 96.06M | 28.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Haleon | 29.74B |
| Hikma Pharmaceuticals | 3.45B |
| HUTCHMED (China) | 1.96B |
| Allergy Therapeutics | 81.94M |
| ECO Animal Health Group | 56.24M |
| Provexis | 17.71M |
| Hellenic Dynamics | 1.32M |
| Chill Brands Group | 836.68K |